Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lucia Del Mastro

Showing results (11-20 of 253) with videos related to

Pageof 26
Sort By:
Recenti Progressi in Medicina|December 20, 2018
[Biosimilars in oncology. Focus on SB3 studies.]Marzia Del Re, Lucia Del Mastro
Recenti Progressi in Medicina|January 8, 2020
[Clinical applications of trastuzumab in the management of HER-2-positive breast cancer.]Lucia Del Mastro, Michelino De Laurentiis
Cancer Treatment Reviews|September 14, 2007
Reducing the risk of distant metastases in breast cancer patients: role of aromatase inhibitorsLucia Del Mastro, Matteo Clavarezza, Marco Venturini
Current Opinion in Oncology|August 23, 2019
Role of dose-dense chemotherapy in high-risk early breast cancerEva Blondeaux, Francesca Poggio, Lucia Del Mastro
Breast (Edinburgh, Scotland)|November 3, 2018
Reply to the letter "Safety of fertility preservation in women with breast cancer"Matteo Lambertini, Paola Anserini, Lucia Del Mastro
Cancer Treatment Reviews|July 18, 2006
Infertility and pregnancy after breast cancer: current knowledge and future perspectivesLucia Del Mastro, Tiziana Catzeddu, Marco Venturini
Future Oncology (London, England)|July 11, 2013
Trastuzumab emtansine in the treatment of HER-2-positive metastatic breast cancer patientsClaudia Bighin, Paolo Pronzato, Lucia Del Mastro
Expert Opinion on Pharmacotherapy|August 3, 2017
Luteininzing hormone releasing hormones analogs in combination with tamoxifen for the adjuvant treatment of premenopausal women with hormone receptor positive breast cancerBenedetta Conte, Francesca Poggio, Lucia Del Mastro
European Journal of Cancer (Oxford, England : 1990)|December 30, 2015
Is it safe to perform a controlled ovarian stimulation for assisted reproduction in young breast cancer survivors?Matteo Lambertini, Paola Anserini, Lucia Del Mastro
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 2009
Aromatase inhibitors as adjuvant therapy for breast cancerFilippo Montemurro, Massimo Aglietta, Lucia Del Mastro
Pageof 26

Showing results (11-20 of 253) with videos related to

Sort By:
Pageof 26
Recenti Progressi in Medicina|December 20, 2018
[Biosimilars in oncology. Focus on SB3 studies.]Marzia Del Re, Lucia Del Mastro
Recenti Progressi in Medicina|January 8, 2020
[Clinical applications of trastuzumab in the management of HER-2-positive breast cancer.]Lucia Del Mastro, Michelino De Laurentiis
Cancer Treatment Reviews|September 14, 2007
Reducing the risk of distant metastases in breast cancer patients: role of aromatase inhibitorsLucia Del Mastro, Matteo Clavarezza, Marco Venturini
Current Opinion in Oncology|August 23, 2019
Role of dose-dense chemotherapy in high-risk early breast cancerEva Blondeaux, Francesca Poggio, Lucia Del Mastro
Breast (Edinburgh, Scotland)|November 3, 2018
Reply to the letter "Safety of fertility preservation in women with breast cancer"Matteo Lambertini, Paola Anserini, Lucia Del Mastro
Cancer Treatment Reviews|July 18, 2006
Infertility and pregnancy after breast cancer: current knowledge and future perspectivesLucia Del Mastro, Tiziana Catzeddu, Marco Venturini
Future Oncology (London, England)|July 11, 2013
Trastuzumab emtansine in the treatment of HER-2-positive metastatic breast cancer patientsClaudia Bighin, Paolo Pronzato, Lucia Del Mastro
Expert Opinion on Pharmacotherapy|August 3, 2017
Luteininzing hormone releasing hormones analogs in combination with tamoxifen for the adjuvant treatment of premenopausal women with hormone receptor positive breast cancerBenedetta Conte, Francesca Poggio, Lucia Del Mastro
European Journal of Cancer (Oxford, England : 1990)|December 30, 2015
Is it safe to perform a controlled ovarian stimulation for assisted reproduction in young breast cancer survivors?Matteo Lambertini, Paola Anserini, Lucia Del Mastro
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 2009
Aromatase inhibitors as adjuvant therapy for breast cancerFilippo Montemurro, Massimo Aglietta, Lucia Del Mastro
Pageof 26